RxDoctor Payments Data

Mary Holmes

Family · Moncure, NCNPI 1285060459

Payments from drug & device makers

$1,407in general payments, 2019–2025

Across 67 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$367
  • Novo Nordisk$261
  • Lilly USA, LLC$189
  • AbbVie$180
  • Johnson & Johnson$130
  • Pfizer$98
  • plus $182 from 9 others

What the payments were for

  • Food & beverage$1,407100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,407 in reported general payments places this provider in the 75th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$12,198
Medicare patients
38
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$29,950
Losartan Potassium45$494
Atorvastatin Calcium46$456
Omeprazole25$324
Metoprolol Succinate32$295
Metformin Hcl ErMetformin Hcl16$261
Gabapentin25$258
Amlodipine Besylate34$229
Albuterol Sulfate HfaAlbuterol Sulfate13$217
Levothyroxine Sodium29$209
Testosterone Cypionate11$179
Bupropion XlBupropion Hcl13$169
Fluoxetine Hcl15$157
Pantoprazole Sodium15$150
Lisinopril20$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$261$29,95020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,522 family providers in North Carolina.

Other family in Moncure

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →